Efficacy and Safety of Avapritinib in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter Study
Oncologist 2022 Dec 07;[EPub Ahead of Print], J Li, X Zhang, Y Deng, X Wu, Z Zheng, Y Zhou, S Cai, Y Zhang, J Zhang, K Tao, Y Cui, H Cao, K Shen, J Yu, Y Zhou, W Ren, C Qu, W Zhao, J Hu, W Wang, J Yang, L ShenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.